Author

Megan M. Emori

Observed names: Megan Emori, Megan M Emori

Institutions: Harvard University, Dana-Farber Cancer Institute

Observed institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute

OpenAlex ID: A5016993102

GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract

2015 · Brooke E. Howitt, Megan M. Emori, et al. · The American Journal of Surgical Pathology · 157

Beyond genomics: Critical evaluation of cell line utility for ovarian cancer research

2015 · Kevin M. Elias, Megan M. Emori, et al. · Gynecologic Oncology · 82

The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis

2014 · Megan M Emori, Ronny Drapkin · Reproductive Biology and Endocrinology · 64

Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors

2016 · Kevin M. Elias, Megan M. Emori, et al. · JCI Insight · 46

Granulin, a novel STAT3-interacting protein, enhances STAT3 transcriptional function and correlates with poorer prognosis in breast cancer

2015 · Jennifer E. Yeh, Simion Kreimer, et al. · Genes & Cancer · 27

Abstract A69: The PAX8 cistrome in benign and malignant Mullerian epithelia.

2016 · Kevin M. Elias, Megan Emori, et al. · Clinical Cancer Research

PAX8 and lineage dependence in high grade serous ovarian cancer

2015 · Kevin M. Elias, Megan Emori, et al. · Gynecologic Oncology

Evolving Models of Ovarian Cancer: Defining the Role of PAX8 in Fallopian Tube Tumorigenesis

2015 · Megan M. Emori · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Works count: 9

Citation count: 376

H-index: 5

I10-index: 5